Thrombocytopenia

UKITP Registry

UK Adult Idiopathic Thrombocytopenic Purpura Registry

Symphogen 001-03

A multi-centre, single intravenous dose, exploratory dose-finding, open label trial on the safety and efficacy of Sym001 in the treatment of Immune Thrombocytopenic Purpura (ITP) in RhD positive, nonsplenectomized adult subjects.

Amgen Romiplostim ITP

A Phase 2, Interventional, Single Arm Study Describing Platelet Responses and ITP Remission Rates in Adult Subjects with Immune Thrombocytopenia Purpura Receving Romiplostim.

 
The primary objective is to describe the number of months with a subject platelet response over a 12 month treatment period.
 

The secondary objectives are:

  1. To describe the incidence of ITP remission.
  2. To describe the incidence of splenectomy. 
  3. To describe the incidence of adverse events.